AskBio is developing gene therapies aimed at treating DMD, a severe genetic disorder characterized

AskBio is developing gene therapies aimed at treating DMD, a severe genetic disorder characterized by progressive muscle degeneration. The company is also focused on treatments for various neuromuscular diseases, leveraging its expertise in gene therapy to address these debilitating conditions.AskBio is pioneering gene therapies to treat congestive heart failure, aiming to restore heart function and improve patient outcomes.The company’s pipeline includes therapies for a range of cardiovascular diseases, emphasizing the potential of gene therapy to transform treatment paradigms.